|
1
|
Stuppia L, Capogreco M, Marzo G, et al:
Genetics of syndromic and nonsyndromic cleft lip and palate. J
Craniofac Surg. 22:1722–1726. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Munger RG, Romitti PA, Daack-Hirsch S,
Burns TL, Murray JC and Hanson J: Maternal alcohol use and risk of
orofacial cleft birth defects. Teratology. 54:27–33. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Little J, Cardy A, Arslan MT, Gilmour M
and Mossey PA: Smoking and orofacial clefts: a United Kingdom-based
case-control study. Cleft Palate Craniofac J. 41:381–386. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jia ZL, Shi B, Chen CH, Shi JY, Wu J and
Xu X: Maternal malnutrition, environmental exposure during
pregnancy and the risk of non-syndromic orofacial clefts. Oral Dis.
17:584–589. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hernández-Diaz S, Smith CR, Shen A, et al:
Comparative safety of antiepileptic drugs during pregnancy.
Neurology. 78:1692–1699. 2012.
|
|
6
|
Cech I, Burau KD and Walston J: Spatial
distribution of orofacial cleft defect births in Harris County,
Texas, 1990 to 1994, and historical evidence for the presence of
low-level radioactivity in tap water. South Med J. 100:560–569.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ramirez D, Lammer EJ, Iovannisci DM,
Laurent C, Finnell RH and Shaw GM: Maternal smoking during early
pregnancy, GSTP1 and EPHX1 variants, and risk of isolated orofacial
clefts. Cleft Palate Craniofac J. 44:366–373. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sim E, Fakis G, Laurieri N and Boukouvala
S: Arylamine N-acetyltransferases - from drug metabolism and
pharmacogenetics to identification of novel targets for
pharmacological intervention. Adv Pharmacol. 63:169–205. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mortensen HM, Froment A, Lema G, et al:
Characterization of genetic variation and natural selection at the
arylamine N-acetyltransferase genes in global human populations.
Pharmacogenomics. 12:1545–1558. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Boukouvala S and Fakis G: Arylamine
N-acetyltransferases: what we learn from genes and genomes. Drug
Metab Rev. 37:511–564. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Smelt VA, Mardon HJ and Sim E: Placental
expression of arylamine N-acetyltransferases: evidence for linkage
disequilibrium between NAT1*10 and NAT2*4 alleles of the two human
arylamine N-acetyltransferase loci NAT1 and NAT2. Pharmacol
Toxicol. 83:149–157. 1998.PubMed/NCBI
|
|
12
|
Ward A, Hickman D, Gordon JW and Sim E:
Arylamine N-acetyltransferase in human red blood cells. Biochem
Pharmacol. 44:1099–1104. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Minchin RF: Acetylation of
p-aminobenzoylglutamate, a folic acid catabolite, by recombinant
human arylamine N-acetyltransferase and U937 cells. Biochem J.
307(Pt 1): 1–3. 1995.PubMed/NCBI
|
|
14
|
Erickson RP, Cao W, Acuña DK, et al:
Confirmation of the role of N-acetyltransferase 2 in
teratogen-induced cleft palate using transgenics and knockouts. Mol
Reprod Dev. 75:1071–1076. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lammer EJ, Shaw GM, Iovannisci DM, Van
Waes J and Finnell RH: Maternal smoking and the risk of orofacial
clefts: susceptibility with NAT1 and NAT2 polymorphisms.
Epidemiology. 15:150–156. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lammer EJ, Shaw GM, Iovannisci DM and
Finnell RH: Periconceptional multivitamin intake during early
pregnancy, genetic variation of acetyl-N-transferase 1 (NAT1), and
risk for orofacial clefts. Birth Defects Res A Clin Mol Teratol.
70:846–852. 2004. View Article : Google Scholar
|
|
17
|
Lie RT, Wilcox AJ, Taylor J, et al:
Maternal smoking and oral clefts: the role of detoxification
pathway genes. Epidemiology. 19:606–615. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shi M, Christensen K, Weinberg CR, et al:
Orofacial cleft risk is increased with maternal smoking and
specific detoxification-gene variants. Am J Hum Genet. 80:76–90.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
van Rooij IA, Groenen PM, van Drongelen M,
Te Morsche RH, Peters WH and Steegers-Theunissen RP: Orofacial
clefts and spina bifida: N-acetyltransferase phenotype, maternal
smoking, and medication use. Teratology. 66:260–266.
2002.PubMed/NCBI
|
|
20
|
Komar AA: Silent SNPs: impact on gene
function and phenotype. Pharmacogenomics. 8:1075–1080. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cornish VA, Pinter K, Boukouvala S, et al:
Generation and analysis of mice with a targeted disruption of the
arylamine N-acetyltransferase type 2 gene. Pharmacogenomics J.
3:169–177. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sugamori KS, Wong S, Gaedigk A, et al:
Generation and functional characterization of arylamine
N-acetyltransferase Nat1/Nat2 double-knockout mice. Mol Pharmacol.
64:170–179. 2003. View Article : Google Scholar : PubMed/NCBI
|
